Top Institutions in Hepatology
Institutions leading in hepatology research with expertise in non-invasive liver fibrosis assessment and clinical trials in MASLD/NASH have contributed significantly to validating VCTE as a prognostic tool compared to liver biopsy.
-
#1
Hopital Beaujon
Clichy, France
Home institution of Dr. Laurent Castéra, a leading expert in VCTE and liver fibrosis assessment, with extensive clinical research in MASLD and non-invasive diagnostics.
Key Differentiators
- Hepatology
- Liver Disease Research
-
#2
Mayo Clinic
Rochester, Minnesota
Renowned for pioneering research in liver diseases including MASLD/NASH and expertise in non-invasive fibrosis assessment techniques such as elastography.
Key Differentiators
- Hepatology
- Gastroenterology
- Liver Transplantation
-
#3
Mount Sinai Health System
New York, New York
Strong focus on metabolic liver diseases and development of non-invasive diagnostic tools, with multiple publications on elastography and MASLD outcomes.
Key Differentiators
- Hepatology
- Translational Liver Research
-
#4
University of California, San Diego (UCSD) Health
San Diego, California
Leaders in clinical and translational research on fatty liver disease and fibrosis, with expertise in elastography and liver biopsy correlation studies.
Key Differentiators
- Hepatology
- Liver Disease Clinical Research
-
#5
King's College London
London, United Kingdom
International leader in liver disease research, particularly in elastography technology development and validation in metabolic liver diseases.
Key Differentiators
- Hepatology
- Liver Fibrosis Research
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
